269 related articles for article (PubMed ID: 16862978)
1. [Recent progress in the therapeutic strategy for follicular lymphoma and mantle cell lymphoma].
Ogura M
Rinsho Ketsueki; 2006 Jun; 47(6):495-512. PubMed ID: 16862978
[No Abstract] [Full Text] [Related]
2. [The choice of second-line chemotherapy for malignant lymphoma].
Ikeda T; Hotta T
Gan To Kagaku Ryoho; 2005 Jan; 32(1):6-10. PubMed ID: 15675573
[TBL] [Abstract][Full Text] [Related]
3. Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle cell lymphomas: results of a prospective randomized trial of the German Low-Grade Lymphoma Study Group.
Nickenig C; Dreyling M; Hoster E; Pfreundschuh M; Trumper L; Reiser M; Wandt H; Lengfelder E; Unterhalt M; Hiddemann W;
Cancer; 2006 Sep; 107(5):1014-22. PubMed ID: 16878325
[TBL] [Abstract][Full Text] [Related]
4. Mantle-cell lymphoma (multiple lymphomatous polyposis) of the entire GI tract.
Michopoulos S; Petraki K; Matsouka C; Kastritis E; Chrysanthopoulou H; Dimopoulos MA
J Clin Oncol; 2008 Mar; 26(9):1555-7. PubMed ID: 18349408
[No Abstract] [Full Text] [Related]
5. Fourth biannual report of the Cochrane Haematological Malignancies Group.
Kober T; Hülsewede H; Bohlius J; Engert A
J Natl Cancer Inst; 2006 Apr; 98(8):E1. PubMed ID: 16622111
[No Abstract] [Full Text] [Related]
6. High-dose therapy for follicular lymphoma revisited: not if, but when?
Lister TA
J Clin Oncol; 2003 Nov; 21(21):3894-6. PubMed ID: 14517186
[No Abstract] [Full Text] [Related]
7. CHOP chemotherapy followed by Rituximab consolidation as first line treatment in patients with follicular lymphoma. Long-term follow-up of a phase 2 trial.
Jäger G; Quehenberger F; Linkesch W; Neumeister P
Eur J Haematol; 2007 May; 78(5):453-5. PubMed ID: 17419745
[No Abstract] [Full Text] [Related]
8. [Recent therapeutic progress in non-Hodgkin lymphoma: focusing on diffuse large B-cell lymphoma and follicular lymphoma].
Ogura M
Rinsho Ketsueki; 2008 Oct; 49(10):1434-50. PubMed ID: 18833928
[No Abstract] [Full Text] [Related]
9. Adding rituximab to cyclophosphamide, vincristine and prednisone increases time to treatment failure or progression in people with untreated stage III/IV follicular lymphoma.
Ghielmini M
Cancer Treat Rev; 2005 Dec; 31(8):644-7. PubMed ID: 16289339
[No Abstract] [Full Text] [Related]
10. A high tumor-associated macrophage content predicts favorable outcome in follicular lymphoma patients treated with rituximab and cyclophosphamide-doxorubicin-vincristine-prednisone.
Taskinen M; Karjalainen-Lindsberg ML; Nyman H; Eerola LM; Leppä S
Clin Cancer Res; 2007 Oct; 13(19):5784-9. PubMed ID: 17908969
[TBL] [Abstract][Full Text] [Related]
11. [Milestone in healing fatal indolent lymphoma].
Krankenpfl J; 2004; 42(3-4):106-7. PubMed ID: 15311904
[No Abstract] [Full Text] [Related]
12. Novel treatment strategies in follicular lymphoma.
Buske C; Dreyling H; Unterhalt M; Hiddemann W
Ann Hematol; 2004; 83 Suppl 1():S72. PubMed ID: 15124680
[TBL] [Abstract][Full Text] [Related]
13. Mantle cell lymphoma as a rare cause of intussusception: a report of 2 cases.
Grin A; Chetty R; Bailey D
Ann Diagn Pathol; 2009 Dec; 13(6):398-401. PubMed ID: 19917477
[TBL] [Abstract][Full Text] [Related]
14. Chimeric anti-CD20 monoclonal antibody (Mabthera) in remission induction and maintenance treatment of relapsed follicular non-Hodgkin's lymphoma: a phase III randomized clinical trial--Intergroup Collaborative Study.
Van Oers MH; Hagenbeek A; Van Glabbeke M; Teodorovic I
Ann Hematol; 2002 Oct; 81(10):553-7. PubMed ID: 12424535
[No Abstract] [Full Text] [Related]
15. High-dose Ara-C and beam with autograft rescue in R-CHOP responsive mantle cell lymphoma patients.
van 't Veer MB; de Jong D; MacKenzie M; Kluin-Nelemans HC; van Oers MH; Zijlstra J; Hagenbeek A; van Putten WL
Br J Haematol; 2009 Feb; 144(4):524-30. PubMed ID: 19036081
[TBL] [Abstract][Full Text] [Related]
16. [Antibody therapy in hematology and oncology - part 1].
Kneba M; Schrader C; Köhne H
Med Klin (Munich); 2008 Dec; 103(12):843-59. PubMed ID: 19099214
[No Abstract] [Full Text] [Related]
17. A phase III trial of CHOP vs CHOP + rituximab vs CHOP + 1-131 tositumomab for newly diagnosed follicular non-Hodgkin lymphoma.
Clin Adv Hematol Oncol; 2006 Jul; 4(7):536-8. PubMed ID: 17147240
[No Abstract] [Full Text] [Related]
18. Time to treatment does not influence overall survival in newly diagnosed mantle-cell lymphoma.
Eve HE; Furtado MV; Hamon MD; Rule SA
J Clin Oncol; 2009 Nov; 27(32):e189-90; author reply e191. PubMed ID: 19805667
[No Abstract] [Full Text] [Related]
19. Fatal visceral varicella-zoster infection following rituximab and chemotherapy treatment in a patient with follicular lymphoma.
Bermúdez A; Marco F; Conde E; Mazo E; Recio M; Zubizarreta A
Haematologica; 2000 Aug; 85(8):894-5. PubMed ID: 10942955
[No Abstract] [Full Text] [Related]
20. [Mantle cell lymphoma mimicking chronic lymphocytic leukemia].
Hanamura A; Hayakawa M; Naito K
Rinsho Ketsueki; 2005 Jan; 46(1):13-8. PubMed ID: 16708912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
